These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3360275)

  • 21. The role of intracellular hemoglobin precipitation, low MCHC, and iron overload on red blood cell membrane peroxidation in thalassemia.
    Rachmilewitz EA
    Birth Defects Orig Artic Ser; 1976; 12(8):123-33. PubMed ID: 795476
    [No Abstract]   [Full Text] [Related]  

  • 22. Iron absorption and loading in beta-thalassaemia intermedia.
    Pippard MJ; Callender ST; Warner GT; Weatherall DJ
    Lancet; 1979 Oct; 2(8147):819-21. PubMed ID: 90918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deferasirox in children with transfusion-dependent thalassemia or sickle cell anemia: A large cohort real-life experience from Turkey (REACH-THEM).
    Antmen B; Karakaş Z; Yeşilipek MA; Küpesiz OA; Şaşmaz İ; Uygun V; Kurtoğlu E; Oktay G; Aydogan G; Akın M; Salcioglu Z; Vergin C; Kazancı EG; Ünal S; Çalışkan Ü; Aral YZ; Türkkan E; Meral Güneş A; Tunç B; Gümrük F; Ayhan AC; Söker M; Koç A; Oymak Y; Ertem M; Timur Ç; Yıldırmak Y; İrken G; Apak H; Biner B; Eren TG; Işık Balcı Y; Koçak Ü; Karasu G; Akkaynak D; Patıroğlu T
    Eur J Haematol; 2019 Feb; 102(2):123-130. PubMed ID: 30300449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting therapeutic efficacy for sickle cell anemia.
    Noguchi CT; Rodgers GP; Serjeant G; Schechter AN
    Prog Clin Biol Res; 1987; 251():497-505. PubMed ID: 3432275
    [No Abstract]   [Full Text] [Related]  

  • 25. [Serum ferritin in the follow-up of homozygotic beta-thalassemia treated with blood transfusion and iron-chelating agents].
    Esposito L; Ferrara M; Ponte G
    Pediatria (Napoli); 1981 Sep; 89(3):479-92. PubMed ID: 7346759
    [No Abstract]   [Full Text] [Related]  

  • 26. Two novel missense mutations in iron transport protein transferrin causing hypochromic microcytic anaemia and haemosiderosis: molecular characterization and structural implications.
    Athiyarath R; Arora N; Fuster F; Schwarzenbacher R; Ahmed R; George B; Chandy M; Srivastava A; Rojas AM; Sanchez M; Edison ES
    Br J Haematol; 2013 Nov; 163(3):404-7. PubMed ID: 23888904
    [No Abstract]   [Full Text] [Related]  

  • 27. The management of haemoglobinopathies.
    Davies SC; Wonke B
    Baillieres Clin Haematol; 1991 Apr; 4(2):361-89. PubMed ID: 1912665
    [No Abstract]   [Full Text] [Related]  

  • 28. Inverted cortico-medullary differentiation of renal hemosiderosis.
    Gupta A; Khandelwal A; Khandelwal K
    Saudi J Kidney Dis Transpl; 2014 Jan; 25(1):170-1. PubMed ID: 24434406
    [No Abstract]   [Full Text] [Related]  

  • 29. Assessment of nutritional anaemia in northern Nigeria.
    Leyland MJ; Baksi AK; Brown PJ; Kenny TW; Strange CA
    Ann Trop Med Parasitol; 1979 Feb; 73(1):63-71. PubMed ID: 496465
    [No Abstract]   [Full Text] [Related]  

  • 30. Iron overload? In sickle cell disease?
    Day S; Dancy R; Kelly K; Wang W
    MCN Am J Matern Child Nurs; 1993; 18(6):330-5. PubMed ID: 8295522
    [No Abstract]   [Full Text] [Related]  

  • 31. Transfusion support for haemoglobinopathies.
    Greenwalt TJ; Zelenski KR
    Clin Haematol; 1984 Feb; 13(1):151-65. PubMed ID: 6373080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Longitudinal MRI and Ferritin Monitoring of Iron Overload in Chronically Transfused and Chelated Children With Sickle Cell Anemia and Thalassemia Major.
    Aubart M; Ou P; Elie C; Canniffe C; Kutty S; Delos V; Graffigne C; de Montalembert M; Brousse V
    J Pediatr Hematol Oncol; 2016 Oct; 38(7):497-502. PubMed ID: 27548334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum ferritin in beta-thalassaemia intermedia.
    Lagos P; Lagona E; Kattamis C; Matsaniotis N
    Lancet; 1980 Jan; 1(8161):204-5. PubMed ID: 6101657
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of iron overload in Cooley's anemia.
    Cohen A; Mizanin J; Schwartz E
    Ann N Y Acad Sci; 1985; 445():274-81. PubMed ID: 3860130
    [No Abstract]   [Full Text] [Related]  

  • 35. The increasing complexity of sickle cell anemia.
    Warth JA; Rucknagel DL
    Prog Hematol; 1983; 13():25-47. PubMed ID: 6199811
    [No Abstract]   [Full Text] [Related]  

  • 36. Chelation therapy and ferritin levels in patients with homozygous beta-thalassemia.
    Kattamis C; Lagos P; Langona E
    Prog Clin Biol Res; 1979; 34():351-9. PubMed ID: 531060
    [No Abstract]   [Full Text] [Related]  

  • 37. A comparison of erythrocyte characteristics in sickle cell syndromes in Jamaica.
    Serjeant GR; Serjeant BE
    Br J Haematol; 1972 Aug; 23(2):205-13. PubMed ID: 5070127
    [No Abstract]   [Full Text] [Related]  

  • 38. A study on the value of red cell exchange transfusion in transfusion dependent anaemias.
    Berdoukas VA; Kwan YL; Sansotta ML
    Clin Lab Haematol; 1986; 8(3):209-20. PubMed ID: 3093137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Study of serum hepcidin in hereditary hemolytic anemias.
    El Beshlawy A; Alaraby I; Abdel Kader MS; Ahmed DH; Abdelrahman HE
    Hemoglobin; 2012; 36(6):555-70. PubMed ID: 23088733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A study of serum ferritin in beta thalassemia. Iron deficiency and overload.
    Saraya AK; Kumar R; Choudhry VP; Kailash S; Sehgal AK
    Am J Clin Pathol; 1985 Jul; 84(1):103-7. PubMed ID: 4014070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.